Home > Riviste > Minerva Pediatrics > Fascicoli precedenti > Articles online first > Minerva Pediatrica 2019 Apr 05

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

 

Minerva Pediatrica 2019 Apr 05

DOI: 10.23736/S0026-4946.19.05142-9

Copyright © 2019 EDIZIONI MINERVA MEDICA

lingua: Inglese

Weaning in Neurally Adjusted Ventilatory Assist (NAVA): a prospective interventional study in neonates

Gianluca COSI 1, Alice MONZANI 2, Giulia GENONI 2 , Simona DE FRANCO 1, Silvia PARLAMENTO 2, Gianni BONA 2, Federica FERRERO 1

1 Neonatal and Paediatric Intensive Care Unit, Maggiore della Carità Hospital, Novara, Italy; 2 Division of Paediatrics, Department of Health Sciences, University of Piemonte Orientale, Novara, Italy


PDF


BACKGROUND: Neurally adjusted ventilatory assist (NAVA) is a respiratory support triggered by the electrical activity of the diaphragm (EAdi). Only few studies evaluated NAVA short-term efficacy and safety in newborns. Aim of this study is to assess efficacy and safety of NAVA in a cohort of newborns and to analyse ventilation parameters helpful to guide weaning.
METHODS: Thirty-four newborns with respiratory failure were ventilated with Synchronized Intermittent Mandatory Ventilation plus pressure-regulated volume control plus pressure support (SIMV(PRVC)+PS) for 12 hours and switched to NAVA until extubation. Ventilator and vital parameters, oxygen saturation (SpO2)/fraction of inspired oxygen (FiO2) ratio (S/F), arterialized capillary blood gases (aCBG), and sedatives dose were recorded. The occurrence of re-intubation within the first 72 hours, pneumothorax and mortality were evaluated.
RESULTS: After 6 hours of NAVA, a significant reduction of FiO2 (0.25 versus 0.32), and peak inspiratory pressure (13 versus 18 mmHg), and a significant increase of S/F (383 versus 316) were found, compared to SIMV(PRVC)+PS. Other ventilation, vital and aCBG parameters were similar in both ventilation modes. During NAVA a significant reduction of sedation was shown. All subjects were successfully extubated guided by EAdi peak during weaning. No re- intubation, pneumothorax, or death were recorded.
CONCLUSIONS: NAVA can be effectively and safely used in neonates. The EAdi peak could be a reliable index to guide the physicians during weaning and extubation.


KEY WORDS: Efficacy - Neurally Adjusted Ventilatory Assist - Newborn - Outcome - Safety - Weaning

inizio pagina